JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB94968

Anti-Respiratory Syncytial Virus Fusion (F) Glycoprotein antibody [RSV5A6]

Be the first to review this product! Submit a review

|

(13 Publications)

Anti-Respiratory Syncytial Virus Fusion (F) Glycoprotein antibody [RSV5A6] (ab94968) is a mouse monoclonal antibody detecting Respiratory Syncytial Virus Fusion (F) Glycoprotein in Western Blot, IHC-P, IHC-Fr, ICC/IF, ELISA.

- Trusted since 2010

View Alternative Names

Fusion glycoprotein F0, F

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

RSV5A6

Isotype

IgG2a

Carrier free

No

Reacts with

Respiratory syncytial virus

Applications

ICC/IF, IHC-P, WB, ELISA, IHC-Fr

applications

Immunogen

Cell preparation containing F protein. The exact immunogen used to generate this antibody is proprietary information.

P03420

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ELISA" : {"fullname" : "ELISA", "shortname":"ELISA"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "IHCFr" : {"fullname" : "Immunohistochemistry (Frozen sections)", "shortname":"IHC-Fr"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Respiratory syncytial virus": { "ELISA-species-checked": "guaranteed", "ELISA-species-dilution-info": "", "ELISA-species-notes": "<p></p>", "WB-species-checked": "guaranteed", "WB-species-dilution-info": "", "WB-species-notes": "<p></p>", "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "IHCFr-species-checked": "guaranteed", "IHCFr-species-dilution-info": "", "IHCFr-species-notes": "<p>Fix with Acetone.</p>" } } }

Product details

What is this antibody validated in?
Anti-Respiratory Syncytial Virus Fusion (F) Glycoprotein antibody [RSV5A6] (ab94968) is a mouse monoclonal antibody and is validated for use in Western Blot (WB), Immunohistochemistry (IHC-P), Immunohistochemistry (IHC-Fr), Immunocytochemistry/immunofluorescence (ICC/IF), ELISA in Respiratory syncytial virus samples.

What is the molecular weight of Respiratory Syncytial Virus Fusion (F) Glycoprotein?
Anti-Respiratory Syncytial Virus Fusion (F) Glycoprotein [RSV5A6] (ab94968) specifically detects a band for Respiratory Syncytial Virus Fusion (F) Glycoprotein (UniProt: P03420) at a molecular weight of 63kDa.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
Preservative: 0.02% Sodium azide Constituents: 99.98% PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The Respiratory Syncytial Virus (RSV) Fusion (F) Glycoprotein commonly referred to as the F protein is an important protein weighing approximately 70 kDa. This glycoprotein is expressed on the surface of the RSV virus. Its primary mechanical function involves mediating the fusion of the viral envelope with the host cell membrane a critical step in viral entry. By facilitating this fusion process the F protein ensures that the RSV genome gains access to the host cell cytoplasm for replication. Alternate designations for this protein include the fusion (F) protein and anti-RSV F protein reflecting its important role in RSV infectivity.
Biological function summary

The fusion facilitation of the Respiratory Syncytial Virus involves direct interaction with the host cell membrane allowing viral entry. The F protein is a part of the larger RSV virion structure but does not form complexes with other proteins within the virus. Complete understanding of its structure-activity relationship enhances the development of therapeutic agents targeting viral entry. It represents a direct target for antiviral strategies aiming to inhibit the initial stages of infection reducing the spread and impact of RSV infection.

Pathways

Knowledge about the Respiratory Syncytial Virus F protein highlights its involvement in viral entry and fusion pathways. The F protein plays an essential role in the membrane fusion pathway which is a common mechanism among enveloped viruses. It interfaces with cellular proteins during the virus's attempt to penetrate the host cell. Understanding these interactions aids in the larger framework of viral-host interplay contributing to potential therapeutic pathways like inhibitor development.

RSV infection relates the fusion protein directly to respiratory tract illnesses such as bronchiolitis and pneumonia. It serves as an important target for preventing the exacerbation of these conditions especially in infants and the elderly. The protein's role in facilitating viral entry makes it an attractive candidate for vaccine development further supported by the related G protein of RSV in eliciting the immune response. These associations highlight the importance of the F protein not only in understanding RSV pathology but also in devising strategies for disease prevention and treatment.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Fusion glycoprotein F0. Inactive precursor that is cleaved at two sites by a furin-like protease to give rise to the mature F1 and F2 fusion glycoproteins.. Fusion glycoprotein F1. Class I viral fusion protein (PubMed : 23618766). Under the current model, the protein has at least 3 conformational states : pre-fusion native state, pre-hairpin intermediate state, and post-fusion hairpin state (PubMed : 23618766). During viral and plasma cell membrane fusion, the coiled coil regions assume a trimer-of-hairpins structure, positioning the fusion peptide in close proximity to the C-terminal region of the ectodomain (PubMed : 19966279, PubMed : 23618766). The formation of this structure appears to drive apposition and subsequent fusion of viral and cellular membranes leading to delivery of the nucleocapsid into the cytoplasm (PubMed : 23593008, PubMed : 23618766). This fusion is pH independent and occurs at the plasma or endosomal membrane (Probable). The trimer of F1-F2 (F protein) also facilitates the attachment to host cell by binding to host heparan sulfate (PubMed : 10864656). F protein is involved in the entry into the host cell through the interaction with host IGF1R (PubMed : 32494007). This interaction activates PRKCZ/PKCzeta that recruits host NCL/nucleolin to the apical cell surface where it can bind fusion glycoprotein F1 (PubMed : 21841784, PubMed : 32494007). Later in infection, F protein expressed at the plasma membrane of infected cells can mediate fusion with adjacent cells to form syncytia, a cytopathic effect that could lead to tissue necrosis (PubMed : 10438814). F protein may trigger p53-dependent apoptosis (PubMed : 18216092).. Fusion glycoprotein F2. Major determinant of the species specificity of RSV infection (PubMed : 12663767). The trimer of F1-F2 (F protein) also facilitates the attachment to host cell by binding to host heparan sulfate (PubMed : 10864656). F protein is involved in the entry into the host cell through the interaction with host IGF1R (PubMed : 32494007). This interaction activates PRKCZ/PKCzeta that recruits host NCL/nucleolin to the apical cell surface where it can bind fusion glycoprotein F1 (PubMed : 32494007). Later in infection, F protein expressed at the plasma membrane of infected cells can mediate fusion with adjacent cells to form syncytia, a cytopathic effect that could lead to tissue necrosis (PubMed : 10438814). F protein seems to trigger p53-dependent apoptosis (PubMed : 18216092).
See full target information F

Publications (13)

Recent publications for all applications. Explore the full list and refine your search

Frontiers in immunology 16:1576069 PubMed40589746

2025

Cordycepin, lactoferrin, and Sargassum fusiforme polysaccharides protects against RSV via M2-like macrophage polarization.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaozong Fu,Panwen Huang,Yuting Zhang,Yanchang Li,Shichang Hu

Acta pharmaceutica Sinica. B 14:4443-4460 PubMed39525571

2024

Targeted isolation of antiviral cinnamoylphloroglucinol-terpene adducts from by building blocks-based molecular networking approach.

Applications

Unspecified application

Species

Unspecified reactive species

Jianguo Song,Ruili Huang,Jialiao Cai,Zhenlong Wu,Lijun Hu,Wanyang Sun,Xiaojun Huang,Rongrong He,Wei Tang,Wencai Ye,Ying Wang

Journal of virology 98:e0153624 PubMed39508604

2024

Both chebulagic acid and punicalagin inhibit respiratory syncytial virus entry via multi-targeting glycoprotein and fusion protein.

Applications

Unspecified application

Species

Unspecified reactive species

Yingcai Xiong,Keyu Tao,Tao Li,Yinghui Zhou,Zhaowei Zhang,Weiying Ou,Zhao Wang,Shouchuan Wang,Yayi Hou,Peng Cao,Jianjian Ji

mBio 15:e0138524 PubMed39162560

2024

A new mechanism of respiratory syncytial virus entry inhibition by small-molecule to overcome K394R-associated resistance.

Applications

Unspecified application

Species

Unspecified reactive species

Qiaoyun Song,Haoyue Zhu,Manlan Qiu,Jialiao Cai,Yun Hu,Haixia Yang,Shuwen Rao,Yaolan Li,Manmei Li,Lijun Hu,Shuqin Wang,Jian Hong,Wencai Ye,Heru Chen,Ying Wang,Wei Tang

The Journal of infectious diseases 227:1396-1406 PubMed36550077

2022

Influenza A and Respiratory Syncytial Virus Trigger a Cellular Response That Blocks Severe Acute Respiratory Syndrome Virus 2 Infection in the Respiratory Tract.

Applications

Unspecified application

Species

Unspecified reactive species

Kieran Dee,Verena Schultz,Joanne Haney,Laura A Bissett,Callum Magill,Pablo R Murcia

Journal of virology 95:e0120521 PubMed34379500

2021

Mechanism of Cross-Resistance to Fusion Inhibitors Conferred by the K394R Mutation in Respiratory Syncytial Virus Fusion Protein.

Applications

Unspecified application

Species

Unspecified reactive species

Wei Tang,Yueyue Li,Qiaoyun Song,Ziqin Wang,Manmei Li,Qiwei Zhang,Ying Wang,Wencai Ye,Yaolan Li

Nature 595:596-599 PubMed34234347

2021

A condensate-hardening drug blocks RSV replication in vivo.

Applications

Unspecified application

Species

Unspecified reactive species

Jennifer Risso-Ballester,Marie Galloux,Jingjing Cao,Ronan Le Goffic,Fortune Hontonnou,Aude Jobart-Malfait,Aurore Desquesnes,Svenja M Sake,Sibylle Haid,Miaomiao Du,Xiumei Zhang,Huanyun Zhang,Zhaoguo Wang,Vincent Rincheval,Youming Zhang,Thomas Pietschmann,Jean-François Eléouët,Marie-Anne Rameix-Welti,Ralf Altmeyer

Virus research 295:198277 PubMed33476693

2021

Repurposing of antiparasitic niclosamide to inhibit respiratory syncytial virus (RSV) replication.

Applications

Unspecified application

Species

Unspecified reactive species

Nattamon Niyomdecha,Ornpreya Suptawiwat,Chompunuch Boonarkart,Arunee Thitithanyanont,Prasert Auewarakul

Journal of virology 94: PubMed32102886

2020

Long Noncoding RNA NRAV Promotes Respiratory Syncytial Virus Replication by Targeting the MicroRNA miR-509-3p/Rab5c Axis To Regulate Vesicle Transportation.

Applications

Unspecified application

Species

Unspecified reactive species

Jian Li,Miao Li,Xiuli Wang,Mengfei Sun,Cuiqing Ma,Wenzhang Liang,Xue Gao,Lin Wei

Molecular & cellular proteomics : MCP 19:793-807 PubMed32075873

2020

The Secretome Profiling of a Pediatric Airway Epithelium Infected with hRSV Identified Aberrant Apical/Basolateral Trafficking and Novel Immune Modulating (CXCL6, CXCL16, CSF3) and Antiviral (CEACAM1) Proteins.

Applications

Unspecified application

Species

Unspecified reactive species

Olivier Touzelet,Lindsay Broadbent,Stuart D Armstrong,Waleed Aljabr,Elaine Cloutman-Green,Ultan F Power,Julian A Hiscox
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com